New Non-mRNA 'Emergency' Vaccine Authorized for COVID

People are waking up and the FDA is getting desperate.

STORY AT-A-GLANCE

• September 11, 2023, the U.S. Food and Drug Administration approved reformulated monovalent COVID shots by Pfizer and Moderna for use in individuals 12 years of age and older. They also issued emergency use authorization (EUA) for use of the reformulated jabs in children aged 6 months to 11 years

• October 3, 2023, the FDA issued EUA for an…